Insider · CIK 0001775394
Leslie D. Funtleyder
Files at APLT (Applied Therapeutics, Inc.), RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). First filing Feb 7, 2025, latest Mar 6, 2025.
Leslie D. Funtleyder files SEC Form 4 as director and CFO at APLT (Applied Therapeutics, Inc.), and also at RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). Since Feb 7, 2025, Leslie D. Funtleyder has reported 0 open-market buys worth $0 and 2 open-market sells worth $20k, the latest filed on Mar 6, 2025.
A track record needs three past buys with six months of prices behind them; Leslie D. Funtleyder has 0, so none is measured yet.
The newest scored trade: sold $6,381 of APLT on Mar 4, 2025, filed Mar 6, 2025, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Applied Therapeutics, Inc. | $6,381 14,502 shares | -4% | - | |
| 30Weak | Applied Therapeutics, Inc. | $14k 22,950 shares | -5% | - |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +1,187,500 | $0.00 | $0 | 2,527,959 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Common Stock | -2,375,000 | - | - | 152,959 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | UTender of shares Common Stock | -152,959 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,460 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,230 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -150,000 | - | - | 0 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -40,502 | - | - | 0 | Feb 3, 2026 |
| Jan 1, 2026 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,340,459 | Jan 2, 2026 |
| Dec 18, 2025 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | AGrant or award Stock Option (right to buy)derivative | +8,200 | $0.00 | $0 | 8,200 | Dec 19, 2025 |
| Oct 1, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,190,459 | Oct 1, 2025 |
| Jun 9, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 787,121 | Jul 3, 2025 |
| Jul 1, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 937,121 | Jul 3, 2025 |
| Mar 24, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +350,000 | $0.00 | $0 | 740,459 | Mar 26, 2025 |
| Mar 4, 2025 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -14,502 | $0.44 | $6,381 | 390,459 | Mar 6, 2025 |
| Feb 6, 2025 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -22,950 | $0.61 | $14k | 404,961 | Feb 7, 2025 |
| Dec 19, 2024 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 427,911 | Dec 20, 2024 |
| Dec 19, 2024 | APLT Applied Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Dec 20, 2024 |
| Dec 10, 2024 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | AGrant or award Stock Option (right to buy)derivative | +8,200 | $0.00 | $0 | 8,200 | Dec 12, 2024 |
Questions about Leslie D. Funtleyder
Answered from the filings on this page, as of the latest one.
Is Leslie D. Funtleyder buying or selling?
Not in the last 12 months. Leslie D. Funtleyder's latest open-market trade on SEC Form 4 was sold $6,381 of APLT on Mar 4, 2025.
How did Leslie D. Funtleyder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Leslie D. Funtleyder has 0.
Where does Leslie D. Funtleyder file Form 4?
Leslie D. Funtleyder has filed Form 4 at APLT (Applied Therapeutics, Inc.) as Chief Financial Officer; RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.